Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-30

Clinical Trial Update: Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether tamsulosin reduces the incidence and duration of postoperative urinary retention after spine surgery; the study was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Mayo Clinic | Conditions: Postoperative Urinary Retention | Phase 3 | Status: TERMINATED | Results posted: 2024-05-30